These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24018262)

  • 41. Phenotypic and genotypic quinolone resistance in Escherichia coli underlining GyrA83/87 mutations as a target to detect ciprofloxacin resistance.
    Muggeo A; Cambau E; Amara M; Micaëlo M; Pangon B; Bajolet O; Benmansour H; de Champs C; Guillard T
    J Antimicrob Chemother; 2020 Sep; 75(9):2466-2470. PubMed ID: 32443149
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased prevalence of plasmid-mediated quinolone resistance determinants in chicken Escherichia coli isolates from 2001 to 2007.
    Huang SY; Dai L; Xia LN; Du XD; Qi YH; Liu HB; Wu CM; Shen JZ
    Foodborne Pathog Dis; 2009 Dec; 6(10):1203-9. PubMed ID: 19735206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of plasmid-mediated quinolone resistance in Escherichia coli isolates in Wenzhou, Southern China, 2002-2008.
    Zhou TL; Chen XJ; Zhou MM; Zhao YJ; Luo XH; Bao QY
    Jpn J Infect Dis; 2011; 64(1):55-7. PubMed ID: 21266756
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
    Xu X; Wu S; Ye X; Liu Y; Shi W; Zhang Y; Wang M
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4105-10. PubMed ID: 17724159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro selection of resistance to pradofloxacin and ciprofloxacin in canine uropathogenic Escherichia coli isolates.
    Liu X; Lazzaroni C; Aly SA; Thungrat K; Boothe DM
    Vet Microbiol; 2014 Dec; 174(3-4):514-522. PubMed ID: 25465666
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular epidemiological survey on quinolone resistance genotype and phenotype of Escherichia coli in septicemic broilers in Hebei, China.
    Xie R; Huo S; Li Y; Chen L; Zhang F; Wu X
    Poult Sci; 2014 Feb; 93(2):335-9. PubMed ID: 24570454
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutations in DNA Gyrase and Topoisomerase IV in Ciprofloxacin-Nonsusceptible Extended-Spectrum -Lactamase-Producing Escherichia coli and Klebsiella pneumoniae.
    Park KS; Yang HS; Nam YS; Lee HJ
    Clin Lab; 2017 Mar; 63(3):535-541. PubMed ID: 28271673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
    Zhao X; Quinn B; Kerns R; Drlica K
    J Antimicrob Chemother; 2006 Dec; 58(6):1283-6. PubMed ID: 17003060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasmid-mediated quinolone resistance determinants among Gram-negative bacteraemia isolates: a hidden threat.
    Margaritis A; Galani I; Chatzikonstantinou M; Petrikkos G; Souli M
    J Med Microbiol; 2017 Mar; 66(3):266-275. PubMed ID: 27902429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Unexpected Activity of Oral Fosfomycin against Resistant Strains of Escherichia coli in Murine Pyelonephritis.
    Pourbaix A; Guérin F; Burdet C; Massias L; Chau F; Cattoir V; Fantin B
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31160291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of gyrA Mutations in Nalidixic Acid-Resistant Strains of Salmonella Enteritidis Isolated from Humans, Food, Chickens, and the Farm Environment in Brazil.
    Campioni F; Souza RA; Martins VV; Stehling EG; Bergamini AMM; Falcão JP
    Microb Drug Resist; 2017 Jun; 23(4):421-428. PubMed ID: 27559761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro bactericidal activity of enrofloxacin against gyrA mutant and qnr-containing Escherichia coli isolates from animals.
    Cengiz M; Sahinturk P; Sonal S; Buyukcangaz E; Sen A; Arslan E
    Vet Rec; 2013 May; 172(18):474. PubMed ID: 23605176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates.
    Bansal S; Tandon V
    Int J Antimicrob Agents; 2011 Mar; 37(3):253-5. PubMed ID: 21236644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characteristics of quinolone-resistant Escherichia coli isolated from bovine mastitis in China.
    Yang F; Zhang S; Shang X; Wang L; Li H; Wang X
    J Dairy Sci; 2018 Jul; 101(7):6244-6252. PubMed ID: 29605334
    [TBL] [Abstract][Full Text] [Related]  

  • 55. qnr, aac(6')-Ib-cr and qepA genes in Escherichia coli and Klebsiella spp.: genetic environments and plasmid and chromosomal location.
    Ruiz E; Sáenz Y; Zarazaga M; Rocha-Gracia R; Martínez-Martínez L; Arlet G; Torres C
    J Antimicrob Chemother; 2012 Apr; 67(4):886-97. PubMed ID: 22223228
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo efficacies of levofloxacin and ciprofloxacin in acute murine hematogenous pyelonephritis induced by methicillin-susceptible and-resistant Staphylococcus aureus strains.
    Frosco MB; Melton JL; Stewart FP; Kulwich BA; Licata L; Barrett JF
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2529-34. PubMed ID: 8913458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of quinolones for use in detection of determinants of acquired quinolone resistance, including the new transmissible resistance mechanisms qnrA, qnrB, qnrS, and aac(6')Ib-cr, in Escherichia coli and Salmonella enterica and determinations of wild-type distributions.
    Cavaco LM; Aarestrup FM
    J Clin Microbiol; 2009 Sep; 47(9):2751-8. PubMed ID: 19571019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of plasmid mediated quinolone resistance determinants in ciprofloxacin resistant-Escherichia coli from chicken meat produced by integrated broiler operations in Korea.
    Seo KW; Lee YJ
    Int J Food Microbiol; 2019 Oct; 307():108274. PubMed ID: 31404780
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark.
    Cavaco LM; Frimodt-Møller N; Hasman H; Guardabassi L; Nielsen L; Aarestrup FM
    Microb Drug Resist; 2008 Jun; 14(2):163-9. PubMed ID: 18500921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
    Christiansen N; Nielsen L; Jakobsen L; Stegger M; Hansen LH; Frimodt-Møller N
    Microb Drug Resist; 2011 Sep; 17(3):395-406. PubMed ID: 21668371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.